Increased expression of IGF-binding protein-5 in Duchenne Muscular Dystrophy (DMD) fibroblasts correlates with the fibroblast-induced downregulation of DMD myoblast growth: An in vitro analysis

Journal of Cellular Physiology

Volumn 185, Issue 1, 2000, Pages 143-153

  Melone, Mariarosa A B ^a   Peluso, Gianfranco ^b   Galderisi, Umberto ^a   Petillo, Orsolina ^b   Cotrufo, Roberto ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b Institute of Protein Biochemistry and Enzymology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 5;

ANTIBODY SPECIFICITY; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FIBROBLAST CULTURE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE BIOPSY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL COMMUNICATION; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; FIBROBLASTS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE;

TRIXIS;

EID: 0033838429     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4652(200010)185:1<143::AID-JCP14>3.0.CO;2-U     Document Type: Article

References (41)

1. Structure and chromosomal localization of human insuline-like growth factor-binding protein genes
2. Regulation of skeletal-muscle satellite cell-proliferation and differentiation by transforming growth factor-beta, insulin-like growth factor-I, and fibroblast growth-factor
3. Insulin-like growth factor-binding protein-5 (IG-FBP-5) stimulates phosphorylation of the IGFBP-5 receptor
4. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system
5. Purification of human muscle satellite cells by flow cytometry
6. A satellite cell mitogen from crushed adult muscle
7. Cell cycle commitment of rat satellite cells
8. Defective myoblasts identified in Duchenne muscular dystrophy
9. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
10. Association of dystrophin and an integral membrane glycoprotein
11. Partial characterization of skeletal myoblast mitogens in mouse crushed muscle extract
12. Separation of mouse crushed muscle extract into distinct mitogenic activities by heparin affinity chromatography
13. Competition for binding to insuline-like growth factor (IGF) binding protein-2, -3, -4, and -5 by the IGFs and IGF analogs
14. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion
15. Structural and biological characterization of bovine insulin-like growth factor binding protein-3
16. Insuline-like growth factors I and II, messenger ribonucleic acid and gene structures, serum and tissue concentrations
17. Comparison between the growth pattern of cell cultures from normal and Duchenne dystrophy muscle
18. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts
19. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5
20. Myotonic dystrophy: Antisense oligonucleotide inhibition of DMPK gene expression in vitro
21. Insulin-like growth factor binding protein 3 accumulates to high levels in culture medium of senescent and quiescent human fibroblasts
22. Proteins in tissue extracts which bind insulin-like growth factor binding protein-3 (IGFBP-3)
23. A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation
24. Insulin-like growth factors and their binding proteins: Biological actions
25. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
26. Transforming growth factor-beta stimulates production of insulin-like growth factor-binding protein-3 by human skin fibroblasts
27. Insulin-like growth factor binding protein-3: Biochemistry and physiology
28. Release of fibroblast IGFBPs by TGF-beta and IGF-I occurs through distinct mechanism
29. Insulin-like growth factor binding protein secretion by muscle cells: Effect of cellular differentiation and proliferation
30. Effects of cytokines on insulin-like growth factor-binding protein secretion by muscle cells in vitro
31. Antisense oligonucleotides and myotonin gene expression in C2 mouse cells
32. Defective growth 'in vitro 'of Duchenne muscular dystrophy myoblasts: The molecular and biochemical basis
33. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene
34. Inhibition of proliferation in 8-week-old mdx mouse muscle fibroblasts in vitro
35. A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation
36. Cell cycle analysis using continuous bromodeoxyuridine labeling and Hoechst 33258-ethidium bromide bivariate flow cytometry
37. Lymphocyte antigen Leu-19 as a molecular marker of regeneration in human skeletal muscle
38. Peptide growth factors: Current status and therapeutic opportunities
39. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells
40. Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production
41. Inhibition of the DNA synthesis by insulin-like growth factor binding protein 5 (IGF-BPS) in fibroblasts from hindlimb muscle of the 8-week-old male mdx mouse. AFM 6°Colloque sur les maladies neuromusculaires. Versailles, October 21-25, 1996